David A. Sallman. 2020. “To Target the Untargetable: Elucidation of Synergy of APR-246 and Azacitidine in TP53 Mutant Myelodysplastic Syndromes and Acute Myeloid Leukemia”. Haematologica 105 (6). Pavia, Italy, 1470-72. https://doi.org/10.3324/haematol.2020.249060.